Clincosm LogoSign in Get a demo

Advanced Malignant Solid Neoplasm

Showing 51 - 75 of 93
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

Recruiting
  • Advanced Bladder Carcinoma
  • +34 more
  • Atezolizumab
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +113 more
Jun 28, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Afatinib

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Afatinib Dimaleate
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Defactinib

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Defactinib Hydrochloride
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Brunswick,

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • New Brunswick, New Jersey
  • +2 more
Jun 28, 2022

Advanced Malignant Solid Tumor, Extracranial Solid Tumor, Metastatic Malignant Solid Tumor Trial in Palo Alto (Anti-OX40

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Anti-OX40 Antibody BMS 986178
  • TLR9 Agonist SD-101
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Jun 13, 2022

Advanced Malignant Solid Tumor, Bile Duct Carcinoma, Recurrent Malignant Solid Tumor Trial in Indianapolis, Seattle (Afatinib

Completed
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Afatinib Dimaleate
  • +2 more
  • Indianapolis, Indiana
  • +1 more
Jun 3, 2022

Patient Considerations of Social Media Account Management After

Recruiting
  • Advanced Malignant Solid Neoplasm
  • Hematopoietic and Lymphoid System Neoplasm
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
May 24, 2022

Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in San Francisco

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Support Group Therapy
  • +3 more
  • San Francisco, California
    University of California, San Francisco
May 12, 2022

Advanced Malignant Solid Tumor Trial in United States (Adavosertib, Carboplatin, Everolimus)

Completed
Has Results
  • Advanced Malignant Solid Neoplasm
  • Aurora, Colorado
  • +7 more
Apr 11, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Advanced Malignant Solid Tumor Trial in Sacramento (CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc,

Terminated
Has Results
  • Advanced Malignant Solid Neoplasm
  • CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc
  • Placebo Administration
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Mar 8, 2022

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States (Adavosertib)

Suspended
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Duarte, California
  • +8 more
Mar 15, 2022

Advanced Malignant Solid Tumor, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Trifluridine and Tipiracil Hydrochloride
  • Talazoparib Tosylate
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 2, 2022

Advanced Malignant Solid Tumor, Cholangiocarcinoma, Metastatic Malignant Solid Tumor Trial in Columbus (Infigratinib)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 15, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Anti-TGF-beta Monoclonal Antibody SAR-439459
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022

Advanced Malignant Solid Tumor, Extensive Stage Lung Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Los Angeles

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +8 more
  • Atezolizumab
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Feb 7, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Taselisib)

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Feb 4, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Crizotinib)

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Feb 4, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Tumor in the Liver, Metastatic Malignant Tumor in the Lung Trial in Houston

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Hafnium Oxide-containing Nanoparticles NBTXR3
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Advanced Lung Carcinoma, Advanced Malignant Solid Tumor, Malignant Adrenal Gland Tumor Trial in Houston (Anti-CTLA4 Monoclonal

Recruiting
  • Advanced Lung Carcinoma
  • +16 more
  • Anti-CTLA4 Monoclonal Antibody BMS-986218
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2022

Advanced Malignant Solid Tumor, Anorexia, Hematopoietic and Lymphoid Cell Tumor Trial in United States (Olanzapine, Megestrol

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Englewood, Colorado
  • +67 more
Jan 11, 2022

Advanced Malignant Solid Tumor Trial in Houston (Mindfulness Relaxation, Quality-of-Life Assessment, Questionnaire

Recruiting
  • Advanced Malignant Solid Neoplasm
  • Mindfulness Relaxation
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 16, 2021